Hard to Treat Diseases (Hard to Treat Diseases) Receivables Turnover : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Hard to Treat Diseases's Revenue for the three months ended in . 20 was $0.00 Mil. Hard to Treat Diseases's average Accounts Receivable for the three months ended in . 20 was $0.00 Mil.

Hard to Treat Diseases Receivables Turnover Historical Data

The historical data trend for Hard to Treat Diseases's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Receivables Turnover Chart

Hard to Treat Diseases Annual Data

Trend

Receivables Turnover

Hard to Treat Diseases Quarterly Data

Receivables Turnover

Competitive Comparison of Hard to Treat Diseases's Receivables Turnover

For the Biotechnology subindustry, Hard to Treat Diseases's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hard to Treat Diseases's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hard to Treat Diseases's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Hard to Treat Diseases's Receivables Turnover falls into.

Hard to Treat Diseases Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Hard to Treat Diseases's Receivables Turnover for the fiscal year that ended in . 20 is calculated as

	Receivables Turnover (A: . 20 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: . 20 )	/ (	(Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: . 20 ))	/	count )
=		/ (	(	+	)	/	1 )
=		/	0
=	N/A

Hard to Treat Diseases's Receivables Turnover for the quarter that ended in . 20 is calculated as

	Receivables Turnover (Q: . 20 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: . 20 )	/ (	(Accounts Receivable (Q: . 20 )	+	Accounts Receivable (Q: . 20 ))	/	count )
=		/ (	(	+	)	/	1 )
=		/	0
=	N/A

Hard to Treat Diseases (OTCPK:HTDS) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Hard to Treat Diseases Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762

Website

http://www.htdsmedical.com

Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines